Pharmaxis (Pharmaxis) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Pharmaxis Days Sales Outstanding?

Pharmaxis's average Accounts Receivable for the six months ended in Dec. 2023 was $0.79 Mil. Pharmaxis's Revenue for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Pharmaxis's Days Sales Outstanding or its related term are showing as below:

PXSLY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.39 Med: 81.98 Max: 266.89
Current: 266.89

During the past 13 years, Pharmaxis's highest Days Sales Outstanding was 266.89. The lowest was 16.39. And the median was 81.98.

PXSLY's Days Sales Outstanding is ranked worse than
96.7% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 72.57 vs PXSLY: 266.89

Pharmaxis's Days Sales Outstanding declined from Dec. 2022 (715.85) to Dec. 2023 (0.00).

Pharmaxis Days Sales Outstanding Historical Data

The historical data trend for Pharmaxis's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaxis Days Sales Outstanding Chart

Pharmaxis Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

99.68

68.48

85.80

109.31

112.88

Pharmaxis Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															100.54	390.98	715.85	173.07	-

Competitive Comparison of Pharmaxis's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmaxis's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaxis's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmaxis's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Pharmaxis's Days Sales Outstanding falls into.

Pharmaxis Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Pharmaxis's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (1.732	+	0.661)	/	2 )	/	3.869	*	365
=	1.1965					/	3.869	*	365
=	112.88

Pharmaxis's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.661	+	0.919)	/	2 )	/	0	*	365 / 2
=	0.79					/	0	*	365 / 2
=	N/A

Pharmaxis (OTCPK:PXSLY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Pharmaxis Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Pharmaxis's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaxis (Pharmaxis) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmaxis Ltd (OTCPK:PXSLY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

UUDA:Germany SNT:Australia

Address

20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.pharmaxis.com.au

Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.

Pharmaxis (Pharmaxis) Headlines

From GuruFocus

FDA Bronchitol Approval to Generate Cash Flows for Pharmaxis

By Business Wire Business Wire • 11-02-2020

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

By PRNewswire PRNewswire • 08-05-2021

Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial

By PRNewswire PRNewswire • 08-31-2021

Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial

By PRNewswire PRNewswire • 10-05-2021

FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer

By PRNewswire PRNewswire • 11-09-2021

Pharmaxis Commences Final Cohort Dosing in Bone Marrow Cancer Phase 1c Trial

By PRNewswire PRNewswire • 08-04-2021